Currently more than 5.4 million Americans are living with Alzheimer's disease, a number that could triple by 2050 unless advances are made in early detection, treatments and prevention. Second Opinion Live hosts Dr. Michael Greenberg and Dr. Matt Birnholz discuss the many benefits for patients who receive an early diagnosis of Alzheimer's disease, one of which is the ability to participate in a clinical trial, with guest Dr. Shellie Williams from The University of Chicago Medical Center and the Alzheimer's Association.
Our Second Opinion Live hosts also discuss the latest national survey on the state of American Health with Dr. Reed Tuckson from the United Health Foundation.
Broadcast Funding for this program was provided in part by the Alzheimer's Association and its free nation-wide Alzheimer's clinical trials matching service - TrialMatchTM.
Facebook Comments